Literature DB >> 23047754

Delayed amyloid plaque deposition and behavioral deficits in outcrossed AβPP/PS1 mice.

Brian A Couch1, Meghan E Kerrisk, Adam C Kaufman, Haakon B Nygaard, Stephen M Strittmatter, Anthony J Koleske.   

Abstract

Alzheimer's disease (AD) is a progressive neurodegenerative dementia characterized by amyloid plaque accumulation, synapse/dendrite loss, and cognitive impairment. Transgenic mice expressing mutant forms of amyloid-β precursor protein (AβPP) and presenilin-1 (PS1) recapitulate several aspects of this disease and provide a useful model system for studying elements of AD progression. AβPP/PS1 mice have been previously shown to exhibit behavioral deficits and amyloid plaque deposition between 4-9 months of age. We crossed AβPP/PS1 animals with mice of a mixed genetic background (C57BL/6 × 129/SvJ) and investigated the development of AD-like features in the resulting outcrossed mice. The onset of memory-based behavioral impairment is delayed considerably in outcrossed AβPP/PS1 mice relative to inbred mice on a C57BL/6 background. While inbred AβPP/PS1 mice develop deficits in radial-arm water maze performance and novel object recognition as early as 8 months, outcrossed AβPP/PS1 mice do not display defects until 18 months. Within the forebrain, we find that inbred AβPP/PS1 mice have significantly higher amyloid plaque burden at 12 months than outcrossed AβPP/PS1 mice of the same age. Surprisingly, inbred AβPP/PS1 mice at 8 months have low plaque burden, suggesting that plaque burden alone cannot explain the accompanying behavioral deficits. Analysis of AβPP processing revealed that elevated levels of soluble Aβ correlate with the degree of behavioral impairment in both strains. Taken together, these findings suggest that animal behavior, amyloid plaque deposition, and AβPP processing are sensitive to genetic differences between mouse strains.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23047754      PMCID: PMC3562562          DOI: 10.1002/cne.23239

Source DB:  PubMed          Journal:  J Comp Neurol        ISSN: 0021-9967            Impact factor:   3.215


  62 in total

Review 1.  Dentate gyrus and spatial behaviour.

Authors:  Gilberto Fernando Xavier; Valéria Catelli Infantozzi Costa
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2009-04-16       Impact factor: 5.067

Review 2.  Thirty years of Alzheimer's disease genetics: the implications of systematic meta-analyses.

Authors:  Lars Bertram; Rudolph E Tanzi
Journal:  Nat Rev Neurosci       Date:  2008-10       Impact factor: 34.870

3.  Amyloid beta-induced neuronal hyperexcitability triggers progressive epilepsy.

Authors:  Rimante Minkeviciene; Sylvain Rheims; Marton B Dobszay; Misha Zilberter; Jarmo Hartikainen; Lívia Fülöp; Botond Penke; Yuri Zilberter; Tibor Harkany; Asla Pitkänen; Heikki Tanila
Journal:  J Neurosci       Date:  2009-03-18       Impact factor: 6.167

4.  Two-day radial-arm water maze learning and memory task; robust resolution of amyloid-related memory deficits in transgenic mice.

Authors:  Jennifer Alamed; Donna M Wilcock; David M Diamond; Marcia N Gordon; Dave Morgan
Journal:  Nat Protoc       Date:  2006       Impact factor: 13.491

5.  Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer's disease.

Authors:  Jorge J Palop; Jeannie Chin; Erik D Roberson; Jun Wang; Myo T Thwin; Nga Bien-Ly; Jong Yoo; Kaitlyn O Ho; Gui-Qiu Yu; Anatol Kreitzer; Steven Finkbeiner; Jeffrey L Noebels; Lennart Mucke
Journal:  Neuron       Date:  2007-09-06       Impact factor: 17.173

6.  Alzheimer disease: quantitative structural neuroimaging for detection and prediction of clinical and structural changes in mild cognitive impairment.

Authors:  Linda K McEvoy; Christine Fennema-Notestine; J Cooper Roddey; Donald J Hagler; Dominic Holland; David S Karow; Christopher J Pung; James B Brewer; Anders M Dale
Journal:  Radiology       Date:  2009-02-06       Impact factor: 11.105

7.  Effects of the genetic background on cognitive performances of TG2576 mice.

Authors:  Jean Michel Lassalle; Hélène Halley; Stéphanie Daumas; Laure Verret; Bernard Francés
Journal:  Behav Brain Res       Date:  2008-03-21       Impact factor: 3.332

Review 8.  Core candidate neurochemical and imaging biomarkers of Alzheimer's disease.

Authors:  Harald Hampel; Katharina Bürger; Stefan J Teipel; Arun L W Bokde; Henrik Zetterberg; Kaj Blennow
Journal:  Alzheimers Dement       Date:  2007-12-21       Impact factor: 21.566

9.  Expression of transgenic APP mRNA is the key determinant for beta-amyloid deposition in PS2APP transgenic mice.

Authors:  Laurence Ozmen; Anita Albientz; Christian Czech; Helmut Jacobsen
Journal:  Neurodegener Dis       Date:  2008-11-05       Impact factor: 2.977

10.  Comparison of Abeta levels in the brain of familial and sporadic Alzheimer's disease.

Authors:  E Hellström-Lindahl; M Viitanen; A Marutle
Journal:  Neurochem Int       Date:  2009-03-20       Impact factor: 3.921

View more
  4 in total

Review 1.  Improving the predictive value of interventional animal models data.

Authors:  Caroline J Zeiss
Journal:  Drug Discov Today       Date:  2014-11-04       Impact factor: 7.851

2.  Early Activation of Experience-Independent Dendritic Spine Turnover in a Mouse Model of Alzheimer's Disease.

Authors:  Jacqueline K Heiss; Joshua Barrett; Zizi Yu; Laura T Haas; Mikhail A Kostylev; Stephen M Strittmatter
Journal:  Cereb Cortex       Date:  2017-07-01       Impact factor: 5.357

3.  Chronic Microdose Lithium Treatment Prevented Memory Loss and Neurohistopathological Changes in a Transgenic Mouse Model of Alzheimer's Disease.

Authors:  Marielza Andrade Nunes; Natalia Mendes Schöwe; Karla Cristina Monteiro-Silva; Ticiana Baraldi-Tornisielo; Suzzanna Ingryd Gonçalves Souza; Janaina Balthazar; Marilia Silva Albuquerque; Ariadiny Lima Caetano; Tania Araujo Viel; Hudson Sousa Buck
Journal:  PLoS One       Date:  2015-11-25       Impact factor: 3.240

4.  Activation of the sweet taste receptor, T1R3, by the artificial sweetener sucralose regulates the pulmonary endothelium.

Authors:  Elizabeth O Harrington; Alexander Vang; Julie Braza; Aparna Shil; Havovi Chichger
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-09-28       Impact factor: 5.464

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.